DRUG RECALLS: JANUARY 2011
JANUARY 2011: ACETADOTE (ACETYLCYSTEINE) INJECTION RECALLED DUE TO PARTICULATE MATTER FOUND IN A SMALL (6 LOTS) NUMBER OF VIALS. THIS PARTICULATE MATTER WAS FROM THE GLASS VIAL PRODUCED BY A FORMER SUPPLIER.
JANUARY 2011: ALBUTEROL SULFATE INHALATION SOLUTION 0.083%, 3ML IN 25, 30, & 60 UNIT DOSE VIALS RECALLED DUE TO MISLABELED UNIT DOSE VIALS. 2.5MG/3ML SINGLE USE VIALS ARE EMBOSSED WITH THE WRONG CONCENTRATION OF 0.5MG/3ML WHICH IT'S CONSIDER AN HEALTH HAZARD. ONLY THE UNIT DOSE VIALS ARE INCORRECTLY EMBOSSED AS CONTAINING 0.5MG/3ML. THE CORRECT CONCENTRATION OF 2.5MG/3ML IS LABELED ON THE PRODUCT FOIL OVERWRAP POUCHES AND SHELF CARTONS.
JANUARY 2011: METRONIDAZOLE TABLETS, 250MG RECALLED DUE TO UNDERWEIGHT TABLETS MEANING THE TABLETS MAY NOT CONTAIN THE FULL AMOUNT OF ACTIVE INGREDIENT IN A SINGLE TABLET WHICH WOULD NOT GIVE THE FULL AMOUNT PRESCRIBED DOSE TO A PATIENT. THE DRUG CAN WORSEN THE INFECTION WHICH COULD BE LIFE THREATENING WHEN TREATING SERIOUS INFECTIONS.
JANUARY 2011: TRIAD ALCOHOL PREP PADS, ALCOHOL SWABS, & ALCOHOL SWAB STICKS RECALLED DUE TO POTENTIAL MICROBIAL CONTAMINATION WITH BACILLUS CEREUS.
JANUARY 2011: ACETAMINOPHEN PRESCRIPTION PRODUCTS LIMITED TO 325MG PER DOSAGE UNIT MAKING THESE PRODUCTS SAFER FOR PATIENTS. THIS WILL HELP REDUCE THE RISK OF SEVERE LIVER INJURY AND ALLERGIC REACTIONS ASSOCIATED WITH ACETAMINOPHEN.
JANUARY 2011: CELERITE SLIMMING CAPSULES RECALLED DUE TO UNDECLARED DRUG INGREDIENT CALLED SIBUTRAMINE (A CONTROLLED SUBSTANCE THAT WAS WITHDRAWN IN OCT 2010 FOR SAFETY REASONS). SIBUTRAMINE IS KNOWN TO INCREASE BLOOD PRESSURE AND PULSE RATE ESPECIALLY FOR PATIENTS WHO HAVE A HISTORY OF CORONARY ARTERY DISEASE, CONGESTIVE HEART FAILURE, ARRHYTHMIAS, AND STROKES.
JANUARY 2011: MORPHINE SULFATE ORAL SOLUTION 100MG PER 5ML (20MG/ML) RECALLED DUE TO REPORTS OF ACCIDENTAL OVERDOSE SUCH AS INVOLVING SERIOUS ADVERSE EFFECTS AND DEATHS.
JANUARY 2011: MULTAQ (DRONEDARONE) A DRUG USED TO TREAT ABNORMAL HEART RHYTHM RECALLED DUE TO CASES OF RARE & SEVERE LIVER INJURY INCLUDING TWO CASES OF ACUTE LIVER FAILURE LEADING TO LIVER TRANSPLANT IN PATIENTS TREATED WITH THE HEART MEDICATION MULTAQ.
